Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antineoplastic agents and pregnancy].

P Grella, A Graziottin, F Sopracordevole

    Minerva Medica
    |June 30, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Establishing a causal link between antineoplastic drugs during pregnancy and gestational changes is currently impossible due to insufficient data. More rigorous studies are needed to evaluate fetal and maternal outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A proof of concept that experience-based management of endometriosis can complement evidence-based guidelines.

    Facts, views & vision in ObGyn·2023
    Same author

    Validation of a clinical tool for vestibular trophism in postmenopausal women.

    Climacteric : the journal of the International Menopause Society·2023
    Same author

    Trend of decreasing length of cervical cone excision during the last 20 years.

    European review for medical and pharmacological sciences·2017
    Same author

    Colposcopic patterns of vaginal intraepithelial neoplasia: a focus on low-grade lesions.

    European review for medical and pharmacological sciences·2017
    Same author

    Detection of occult endocervical glandular dysplasia in cervical conization specimens for squamous lesions.

    Pathology, research and practice·2017
    Same author

    High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV).

    European review for medical and pharmacological sciences·2016
    Same journal

    How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

    Minerva medica·2026
    Same journal

    Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

    Minerva medica·2026
    Same journal

    Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

    Minerva medica·2026
    Same journal

    Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

    Minerva medica·2026
    Same journal

    Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

    Minerva medica·2026
    Same journal

    Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

    Minerva medica·2026
    See all related articles

    Area of Science:

    • Obstetrics & Gynecology
    • Pharmacology
    • Reproductive Medicine

    Context:

    • Antineoplastic (cancer) drugs are increasingly used in women of reproductive age.
    • Pregnancy management in cancer patients presents complex ethical and clinical challenges.
    • Existing literature lacks comprehensive data on drug effects during gestation.

    Purpose:

    • To review the current literature on the relationship between antineoplastic drug exposure and pregnancy outcomes.
    • To highlight the deficiencies in existing studies regarding feto-maternal parameters.
    • To emphasize the need for improved methodologies in reporting drug effects during pregnancy.

    Summary:

    • A review of current literature reveals an inability to establish a definitive causal relationship between antineoplastic drug use and pregnancy modifications.

    Related Experiment Videos

  • Reported data are often deficient in evaluating fetal, perinatal, and post-natal parameters, as well as patient reproductive history.
  • Strict methodological approaches are crucial for studying and reporting feto-maternal parameters.

    • Impact:

    • Highlights critical gaps in understanding the risks of cancer therapies during pregnancy.
    • Underscores the necessity for standardized, high-quality research to guide clinical decision-making.
    • Aims to improve the safety and outcomes for pregnant patients undergoing cancer treatment and their offspring.